Eligibility
Applicant type, geography, program rules and required conditions.
My Organization Fit Score
See how strongly this opportunity fits your organization.
Atlas combines public grant intelligence with the details of your organization to evaluate eligibility, strategic alignment, funding potential, timing, project fit and submission burden.
GrantNIH NCI Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) — RFA-CA-27-005
Atlas Opportunity Score96/100
FundingNCI intends approximately $4.4 million total costs in FY2027 for 3-4 awards. Application budgets are limited to $700,000 in direct costs per year. Maximum project period: 5 years. No cost sharing required.
DeadlineNext application deadline: January 11, 2027 at 5:00 PM local time of the applicant organization. NOFO expires January 12, 2027.
Required next actionThe October 1, 2026 due date has passed, but NCI added a second application due date of January 11, 2027. Eligible glioblastoma therapeutic-development teams should verify the U19 structure, clinical-trial, accrual-site, registration, budget, and submission requirements before advancing.
Current statusActive — second application due date January 11, 2027Source verificationOctober 3, 2026
Tell Atlas Who You Are
Request your organization-specific analysis.
The form will carry the grant context with it, so you only need to provide the details Atlas cannot know from the opportunity itself.
How Atlas Scores Fit
Useful enough to guide action, structured enough to scale.
Strategic Alignment
How directly the organization's goals and use case match the funder's priorities.
Funding Potential
Available dollars, allowable uses, match burden and the amount that can realistically support the project.
Actionability
Deadline, documentation burden, readiness and the practical work required to submit a strong application.
A High Score Is the Beginning
When the fit is strong, Atlas shows you why.
The goal is not to hand you another number. It is to identify the opportunities worth your attention and make the next step obvious.